Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China · Delayed Price · Currency is CNY 26.31
+0.36 (1.39%)
Jun 12, 2026, 3:04 PM CST
SHE:301130 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 22.79 | 21.9 | 40.27 | 50.5 | 40.72 | 52.02 |
Depreciation & Amortization | 35.25 | 35.25 | 22.53 | 18.6 | 18.49 | 18.71 |
Other Amortization | 0.27 | 0.27 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | 0.5 | -1.87 | - | - |
Asset Writedown & Restructuring Costs | 0 | 0 | 0 | 0.17 | 0 | 0.17 |
Loss (Gain) From Sale of Investments | -3.93 | -3.93 | -5 | -10.92 | -6.71 | -1.21 |
Provision & Write-off of Bad Debts | -0.16 | -0.16 | 0.66 | -0.54 | -0.05 | 0.31 |
Other Operating Activities | 0.36 | -0.56 | 0.68 | 0.84 | 0.35 | 0.01 |
Change in Accounts Receivable | 1.25 | 1.25 | -8.05 | 11.78 | 2.03 | -1.02 |
Change in Inventory | -1 | -1 | -0.24 | -7.43 | 5.61 | -6.48 |
Change in Accounts Payable | -1.96 | -1.96 | 3.97 | -4.39 | 9.53 | -0.67 |
Change in Other Net Operating Assets | - | - | - | -3.08 | -3.08 | -3.08 |
Operating Cash Flow | 50.44 | 48.62 | 54.24 | 54.39 | 67.23 | 59.01 |
Operating Cash Flow Growth | -15.85% | -10.37% | -0.26% | -19.10% | 13.92% | -8.57% |
Capital Expenditures | -67.78 | -66.06 | -134.97 | -123.17 | -54.4 | -21.18 |
Sale of Property, Plant & Equipment | - | - | - | 2.6 | - | - |
Cash Acquisitions | - | - | -78.61 | - | - | - |
Investment in Securities | -46.46 | -122.67 | 129 | 202 | -347 | 1 |
Other Investing Activities | 3.16 | 3.08 | 7.02 | 8.94 | 6.99 | 2.12 |
Investing Cash Flow | -111.08 | -185.64 | -77.57 | 90.37 | -394.41 | -18.06 |
Long-Term Debt Issued | - | 11.53 | - | - | - | - |
Long-Term Debt Repaid | - | -10.36 | -0.34 | -0.24 | - | - |
Net Debt Issued (Repaid) | 29.19 | 1.17 | -0.34 | -0.24 | - | - |
Issuance of Common Stock | - | - | - | - | 412.56 | - |
Repurchase of Common Stock | - | - | -100.01 | - | - | - |
Common Dividends Paid | -20.32 | -20.32 | -20.02 | -12.93 | -10.5 | - |
Other Financing Activities | -35.94 | -5 | - | - | -20.72 | -0.06 |
Financing Cash Flow | -27.07 | -24.15 | -120.37 | -13.17 | 381.33 | -0.06 |
Net Cash Flow | -87.72 | -161.17 | -143.69 | 131.59 | 54.15 | 40.89 |
Free Cash Flow | -17.34 | -17.44 | -80.73 | -68.79 | 12.83 | 37.83 |
Free Cash Flow Growth | - | - | - | - | -66.09% | -24.39% |
Free Cash Flow Margin | -7.27% | -7.43% | -31.49% | -30.51% | 5.02% | 13.24% |
Free Cash Flow Per Share | -0.23 | - | -1.04 | -0.85 | 0.17 | 0.62 |
Cash Income Tax Paid | 37.61 | 37.87 | 29.86 | 40.07 | 34.51 | 43.56 |
Levered Free Cash Flow | -25.79 | -22.32 | -87.38 | -68.43 | 2.44 | 15.27 |
Unlevered Free Cash Flow | -25.52 | -22.05 | -87.33 | -68.4 | 2.44 | 15.27 |
Change in Working Capital | -4.14 | -4.14 | -5.4 | -2.39 | 14.43 | -11 |